The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The study will last about 7 weeks and will include 10 back-to-back overnight stays in the research center.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-26; most recent amendment 2026-05-27.
Status change: Recruiting → Completed2026-05-27
Status change: Not Yet Recruiting → Recruiting2025-10-17